Detalles de la búsqueda
1.
Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes.
Haematologica
; 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572567
2.
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY).
Br J Haematol
; 193(1): 63-71, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32926420
3.
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.
Br J Haematol
; 194(2): 365-377, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33959947
4.
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.
Br J Haematol
; 179(3): 471-479, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28857136
5.
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience.
Blood Adv
; 8(4): 878-888, 2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37967358
6.
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.
Hemasphere
; 8(5): e62, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38774657
7.
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.
Blood Adv
; 8(5): 1209-1219, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127279
8.
Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center.
Haematologica
; 98(4): 611-4, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23065511
9.
Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin.
Br J Haematol
; 179(5): 841-843, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27447404
10.
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma.
Blood Adv
; 4(18): 4337-4346, 2020 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32915975
11.
Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital.
Leuk Lymphoma
; 59(7): 1586-1595, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29119842
12.
Gamma-delta T-cell lymphoma of skin, eye and brain presenting with visual loss.
BMJ Case Rep
; 20172017 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28619740
13.
Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma.
Leuk Lymphoma
; 56(3): 703-10, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24913507
14.
Burkitt's lymphoma of an ileal pouch following restorative proctocolectomy.
Inflamm Bowel Dis
; 18(8): E1596-7, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22294426
Resultados
1 -
14
de 14
1
Próxima >
>>